Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 187

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer

Open access
Yeo, Eun-Jin, Cassetta, Luca, Qian, Bin-Zhi, Lewkowich, Ian, Li, Jiu-feng, Stefater, James A., Smith, April N., Wiechmann, Lisa S., Wang, Yihong, Pollard, Jeffrey W., Lang, Richard A.·2014·Cancer Research

Abstract

Oncogenic targets acting in both tumor cells and tumor stromal cells may offer special therapeutic appeal. Interrogation of the Oncomine database revealed that 52 of 53 human breast carcinomas showed substantial upregulation of WNT family ligand WNT7B. Immunolabeling of human mammary carcinoma showed that WNT7B immunoreactivity was associated with both tumor cells and with tumor-associated macrophages. In the MMTV-PymT mouse model of mammary carcinoma, we found tumor progression relied upon WNT7B produced by myeloid cells in the microenvironment. Wnt7b deletion in myeloid cells reduced the mass and volume of tumors due to a failure in the angiogenic switch. In the tumor overall, there was no change in expression of Wnt/β-catenin pathway target genes, but in vascular endothelial cells (VEC), expression of these genes was reduced, suggesting that VECs respond to Wnt/β-catenin signaling. Mechanistic investigations revealed that failure of the angiogenic switch could be attributed to reduced Vegfa mRNA and protein expression in VECs, a source of VEGFA mRNA in the tumor that was limiting in the absence of myeloid WNT7B. We also noted a dramatic reduction in lung metastasis associated with decreased macrophage-mediated tumor cell invasion. Together, these results illustrated the critical role of myeloid WNT7B in tumor progression, acting at the levels of angiogenesis, invasion, and metastasis. We suggest that therapeutic suppression of WNT7B signaling might be advantageous due to targeting multiple aspects of tumor progression. Cancer Res; 74(11); 2962–73. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-13-2421

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 187

Metadata

Authors
Yeo, E.-J., Cassetta, L., Qian, B.-Z., Lewkowich, I., Li, J.-F., Stefater, J. A., Smith, A. N., Wiechmann, L. S., Wang, Y., Pollard, J. W., & Lang, R. A.
Venue
Cancer Research
Published
2014-05-29
Volume
74
Issue
11
Pages
2962-2973
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2067530106
Cited by
187
References
9
FWCI
6.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-13-2421
The paper
Yeo, E.-J., Cassetta, L., Qian, B.-Z., Lewkowich, I., Li, J.-F., Stefater, J. A., Smith, A. N., Wiechmann, L. S., Wang, Y., Pollard, J. W., & Lang, R. A. (2014). Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-13-2421

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.